Cargando…
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection
The recent COVID-19 pandemic is a treatment challenge in the acute infection stage but the recognition of chronic COVID-19 symptoms termed post-acute sequelae SARS-CoV-2 infection (PASC) may affect up to 30% of all infected individuals. The underlying mechanism and source of this distinct immunologi...
Autores principales: | Patterson, Bruce K., Francisco, Edgar B., Yogendra, Ram, Long, Emily, Pise, Amruta, Rodrigues, Hallison, Hall, Eric, Herrera, Monica, Parikh, Purvi, Guevara-Coto, Jose, Triche, Timothy J., Scott, Paul, Hekmati, Saboor, Maglinte, Dennis, Chang, Xaiolan, Mora-Rodríguez, Rodrigo A., Mora, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784688/ https://www.ncbi.nlm.nih.gov/pubmed/35082777 http://dx.doi.org/10.3389/fimmu.2021.746021 |
Ejemplares similares
-
Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC)
por: Patterson, Bruce K., et al.
Publicado: (2023) -
Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning
por: Patterson, Bruce K., et al.
Publicado: (2021) -
Sleep Disturbance Severity and Correlates in Post-acute Sequelae of COVID-19 (PASC)
por: Pena-Orbea, Cinthya, et al.
Publicado: (2023) -
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
por: Sherif, Zaki A, et al.
Publicado: (2023) -
Autonomic Nerve Involvement in Post-Acute Sequelae of SARS-CoV-2 Syndrome (PASC)
por: Chung, Tae Hwan, et al.
Publicado: (2022)